Table 1.
Demographic and clinical characteristics of the study cohort
| Characteristics | Total study cohort (n = 103) | DLR + (n = 31) | DLR − (n = 72) | |
|---|---|---|---|---|
| Male sex | n (%) | 62 (60%) | 18 (58%) | 44 (61%) |
| Age—yr | Median (IQR) | 75 (63–81) | 77 (64–82) | 75 (63–80) |
| Prestroke mRS | Median (IQR) | 0 (0–1) | 0 (0–2) | 0 (0–0) |
| NIHSS | Median (IQR) | 6 (3–13) | 11 (6–18) | 5 (2–10) |
| Large vessel occlusion | n (%) | 43 (42%) | 14 (45%) | 29 (40%) |
| Thrombolysis | n (%) | 27 (26%) | 5 (16%) | 22 (31%) |
| Thrombectomy | n (%) | 31 (30%) | 11 (35%) | 20 (28%) |
| Hypertension | n (%) | 77 (75%) | 24 (77%) | 53 (74%) |
| Atrial fibrillation | n (%) | 29 (28%) | 13 (42%) | 16 (22%) |
| Diabetes mellitus | n (%) | 24 (23%) | 4 (13%) | 20 (28%) |
| Renal failure | n (%) | 5 (5%) | 1 (3%) | 4 (6%) |
| Heart diseases | n (%) | 40 (39%) | 9 (29%) | 31 (43%) |
| Cognitive impairment | n (%) | 4 (4%) | 4 (13%) | 0 (0%) |
| Deep Fazekas | Mean ± SD | 1.17 ± 1.04 | 1.69 ± 1.04) | 0.96 ± 0.98 |
| Periventricular Fazekas | Mean ± SD | 1.23 ± 1.02 | 1.48 ± 0.91 | 1.13 ± 1.06 |
Abbreviations: yr years, IQR interquartile range, mRS modified Rankin Scale, NIHSS National Institute of Health Stroke Scale, DLR + patients with delirium, DLR– patients without delirium